Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Sleep Cycle AB ( (SE:SLEEP) ).
Sleep Cycle reported a weak first quarter, with net sales down 19% to SEK 52.6 million, EBITDA nearly halved and paying subscribers falling to 715,000, though revenue from its smaller B2B segment grew sharply and now accounts for 14.5% of sales. The company is pushing a strategic shift toward higher-value health applications by updating its Sleep Quality Score, launching research collaborations with Carnegie Mellon University and the UK Health Security Agency on disease detection, advancing validation of a sleep apnea screening service with a U.S. CRO, reorganizing its management and workforce, and distributing its Sleep Aid content via a new app integration on ChatGPT as it evolves from a stand-alone app into a broader sleep platform.
More about Sleep Cycle AB
Sleep Cycle AB is a Swedish health technology company that develops AI-based, contactless sleep analysis solutions built on patented technology and a global sleep data platform. The company is expanding from a consumer sleep-tracking app into a broader sleep platform targeting digital health, technology licensing and Medtech markets, aiming to capture rising global demand for sleep and wellness services.
Average Trading Volume: 38,912
Technical Sentiment Signal: Sell
Current Market Cap: SEK378.8M
See more data about SLEEP stock on TipRanks’ Stock Analysis page.